戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1 ) had asymmetric, bilateral amblyopia; 98 met inclusion and exclusion criteria.
2 nce to any study drugs; secondary analyses eliminated these exclusion criteria.
3     Studies were screened with N = 11 meeting the inclusion/exclusion criteria.
4 68.3% women; mean age: 55.6+/-12.2 years) met our inclusion/exclusion criteria.
5                   All cases were included and there were no exclusion criteria.
6 nosis of neurological disorder or cognitive impairment were exclusion criteria.
7 face diseases, intraocular diseases, trauma or surgery were exclusion criterias.
8                       After applying clinical and molecular exclusion criteria, 17.8% were assigned (26.4% could have bee
9                                          After applying the exclusion criteria, 3,558 men were recruited in intervention
10                                             After inclusion/exclusion criteria, 316 eyes were available for analysis; 131
11                            After application of appropriate exclusion criteria, a cohort of 9447 inpatient operations was
12 er screening titles and abstracts against the inclusion and exclusion criteria and assessing full texts, 17 articles were
13                    Thirteen patients met both inclusion and exclusion criteria, and their tissue samples were revisited.
14 posed by Robins and Wang (RW) in a scenario where the study exclusion criteria are based on a variable that must be imput
15 he aim of this study was to determine the optimal inclusion-exclusion criteria for trials to aim for superiority in visua
16                                                             Exclusion criteria include postoperative best-corrected spect
17                                                             Exclusion criteria included anterior leaflet or commissural p
18                                                             Exclusion criteria included case reports, non-English-languag
19                                                             Exclusion criteria included clinical relapse 30 days or fewer
20                                                             Exclusion criteria included hemodialysis frequency >3.5 times
21                                                             Exclusion criteria included neovascular AMD in the interventi
22                                                             Exclusion criteria included other intracerebral hemorrhage ca
23                                                             Exclusion criteria included severe retinal pathology unrelate
24                                                         Key exclusion criteria included uveal or mucosal melanoma, previo
25                                                             Exclusion criteria included: infant ALL, relapsed ALL, and st
26 stematic review of the literature to identify inclusion and exclusion criteria of prospective interventional oligometasta
27                                               Inclusion and exclusion criteria relating to type of paper, population, int
28 ommercial and Medicare payers, we implemented inclusion and exclusion criteria, selected primary end points, and comparat
29                                                       After exclusion criteria-specifically the removal of VFs with high
30                                                       After exclusion criteria, the cohort consisted of 747 patients (med
31 used on 5-Fluorouracil and Gemcitabine because based on our exclusion criteria, they provide the largest numbers of patie
32                                                             Exclusion criteria were age <18 years, ABO incompatibility, r
33                                                             Exclusion criteria were age less than 18 years, no light perc
34                                                             Exclusion criteria were any ophthalmic surgical procedures wi
35                                         After inclusion and exclusion criteria were applied, the study population include
36                                                             Exclusion criteria were as follows: (1) the purpose of the di
37                                                             Exclusion criteria were as follows: age less than 16 years ol
38                                                             Exclusion criteria were being nulliparous, having missing par
39                                                             Exclusion criteria were being too physically unwell to attend
40                                                             Exclusion criteria were Body-Mass index (BMI) > 40, liver met
41                                                             Exclusion criteria were contrast material-enhanced chest CT p
42               A total of 274 patients meeting inclusion and exclusion criteria were identified and 132 patients were incl
43                                                             Exclusion criteria were newly implanted leads, abandoned or e
44                                                             Exclusion criteria were non-DR retinal disease and inability
45                                                         The exclusion criteria were patients who (1) first presented with
46                                                         The exclusion criteria were presenting more than 14 days after in
47                                                             Exclusion criteria were prior intravitreal anti-VEGF treatmen
48                                                             Exclusion criteria were prior radiation treatment on vertebra
49                                                             Exclusion criteria were studies of inflammatory bowel disease
50                                                             Exclusion criteria were: history of dementia, cardiac or intr